Skip to content

YnoraMed

Active Private limited companyfounded 2024active for 1 yearPijpenhof 29A, 3740 Bilzen-HoeseltKBO/BCE: BE 1017.416.073

Lifetime

1 annual account with figures
peak of €187,875 in 2025
€187,875 
peak of €145,840 in 2025
€145,840 
peak of €148,340 in 2025
€148,340 
€45,384 
Board1 name since 2024
1 director
Documentsfilings and deeds
11-09-202642 days late
2025micro format
First year with figures

Key points

from the 2025 annual accounts

Turnover

≈ €470,000 estimated

The micro format states no turnover.

2025 accounts filed 42 days after the deadline

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 11,278 companies had the same profile as YnoraMed has now. Each dot stands for 29 companies, two years later.

96.6%
were still trading
2.6%
stopped another way
0.7%
went bankrupt
  • Micro
  • under 2 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 11,278 companies, not a prediction for YnoraMed. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 10 sharesdeed of 18-12-2024
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1017416073
Incorporation Founding capital of €2,500, 10 shares · Founder: · Appointment: (director) · published on 18-12-2024 · Gazette deed
First establishment Pijpenhof 29A, Bilzen-Hoeselt
All 4 events

Official details

Source: KBO
Status
Active since 16-12-2024Normal situation
Activity
“Het uitoefenen van de geneeskunde door het organiseren, bevorderen en structureren van alle beroepsactiviteiten…” (deed in Dutch)From the articles, 11 activities1 activity on the establishment unit
Establishment unit
2.367.567.8823740 Bilzen-Hoeselt, since 16-12-2024
Financial year end
31 December
Peppol
Reachable since 08-09-2026
Company details

Annual accounts 2025

€193,723
Filing
Filed on 11-09-2026
Financials

Insights on YnoraMed

YnoraMed has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €148,340 and a net result of €145,840.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about YnoraMed

What is the company number of YnoraMed?
The company number of YnoraMed is 1017.416.073. The VAT number is the same number with BE in front: BE 1017.416.073.
Where is YnoraMed based?
The registered office is at Pijpenhof 29A, 3740 Bilzen-Hoeselt.Company details
What is the legal form of YnoraMed?
YnoraMed is a private limited company (BV).
When was YnoraMed founded?
YnoraMed was founded on 16-12-2024.
Is YnoraMed still active?
Yes, YnoraMed is an active enterprise in the KBO register.
What is the turnover of YnoraMed?
The turnover in financial year 2025 is ≈ €470,000. This figure is estimated from the gross margin of €187,875 and 2,459 comparable companies of the same size. It probably lies between €310,000 and €730,000. It is a rough estimate.Financials
Is YnoraMed profitable?
In financial year 2025, YnoraMed made a profit of €145,840.
Where can I find the annual accounts of YnoraMed?
YnoraMed filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.